Recently, significantly elevated serum soluble ST2 (sST2) but not IL-33 has been detected in SLE patients, and the levels of sST2 were found to correlate with the disease activity and severity of these medical conditions. The gene discussed is IL33; the disease is systemic lupus erythematosus.